![Fighting Blindness Canada](https://www.optiknow.ca/wp-content/uploads/2021/03/Research_FBC-Optik-logos-810x338-v2-2.jpg)
New Treatment Target for AMD Identified
Tuesday, July 9 2024 | 13 h 35 min | Vision Science & Research
For people living with wet age-related macular degeneration (AMD), the first line of treatment is anti-VEGF injections Anti-VEGF injections have...
Read More![](https://www.optiknow.ca/wp-content/uploads/2021/03/Research_FBC-Optik-logos-810x338-v2-3.jpg)
Oral Drug Slows Stargardt Disease Progression in Phase 2 Clinical Trial
Tuesday, March 5 2024 | 08 h 05 min | Vision Science & Research
Results from a Phase 2 clinical trial show that an oral drug, Tinlarebant, may slow progression of Stargardt disease Belite Bio, a...
Read More![Fighting Blindness Canada](https://www.optiknow.ca/wp-content/uploads/2021/03/Research_FBC-Optik-logos-810x338-v2-1.jpg)
Vitamin A Supplements do not Improve Vision for Individuals with Retinitis Pigmentosa
Wednesday, February 21 2024 | 07 h 53 min | Vision Science & Research
A new study from Dr Eric Pierce and Dr Jason Comander at Mass Eye and Ear does not show any benefit to taking high-dose vitamin A supplements for...
Read More![](https://www.optiknow.ca/wp-content/uploads/2023/11/Optik-Sept-Oct-Miranda-article-810-x-338.jpg)
Diversity and Inclusion in Eye Care
Thursday, November 30 2023 | 08 h 51 min | Optik Magazine
By Dr Trevor Miranda, OD Canada is an intricate textured tapestry of different cultures Each patient is unique and presents with different...
Read More![](https://www.optiknow.ca/wp-content/uploads/2023/11/Optik-Sept-Oct-Binocular-vision-810-x-338.jpg)
Students and Binocular Vision: The Hidden Obstacle
Tuesday, November 28 2023 | 14 h 36 min | Clinical Practice, Optik Magazine
By Dr Jenny Lee, OD Two weeks into the start of the school year, young adults returning to the lecture hall are frantically requesting...
Read More